Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
225ac-sso110
Small Cell Lung Carcinoma
Ariceum Therapeutics GmbH
P1/2
CC
(45)
23me-00610
Small Cell Lung Carcinoma
23andMe, Inc.
P1/2
CC
(45)
23me-00610
Primary Peritoneal Carcinoma
23andMe, Inc.
P1/2
CC
(45)
3h-10000
Gastric Cancer
3H Pharmaceuticals Co., Ltd.
P1/2
CC
(45)
4SCAR123
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR20
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR22
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR30
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR38
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
4SCAR70
B-Cell Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
64cu-grip b
Renal Cell Carcinoma
Rahul Aggarwal
P1/2
CC
(45)
67cu-sar-bispsma
Castration-Resistant Prostate Carcinoma
Clarity Pharmaceuticals Ltd
P1/2
CC
(45)
68ga-g21
Prostate Adenocarcinoma
First Affiliated Hospital of Fujian Medical University
P1/2
CC
(45)
68ga-g23
Prostate Adenocarcinoma
First Affiliated Hospital of Fujian Medical University
P1/2
CC
(45)
[68ga]ga-dpi-4452
Urothelial Carcinoma
ITM Oncologics GmbH
P1/2
CC
(45)
68ga-p15-041
Metastatic Prostate Carcinoma
Peking Union Medical College Hospital
P1/2
CC
(45)
(90Y)-PENTIXATHER
Primary Central Nervous System Lymphoma
Pentixapharm AG
P1/2
CC
(45)
a2/4-1bbl melanoma vaccine
Melanoma
Hadassah Medical Organization
P1/2
CC
(45)
a2b543
Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b543
Malignant Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b543
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b694
Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b694
Malignant Mesothelioma
A2 Biotherapeutics Inc.
P1/2
CC
(45)
a2b694
Pancreatic Neoplasm
A2 Biotherapeutics Inc.
P1/2
CC
(45)
ab-1001 gene therapy
Huntington Disease
AskBio France, SAS, a subsidiary of AskBio Inc.
P1/2
CC
(45)
Showing 2876 to 2900 of 6,305 assets
Previous
Page 116 of 253
Next